We've found
161,353
archived clinical trials in
Cancer
We've found
161,353
archived clinical trials in
Cancer
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Updated: 7/31/2015
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Updated: 7/31/2015
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)